Antengene Corporation Limited (HKG:6996)
Hong Kong · Delayed Price · Currency is HKD 4.780
-0.460 (-8.78%)
Aug 1, 2025, 4:08 PM HKT
Antengene Corporation Market Cap
Antengene Corporation has a market cap or net worth of 3.25 billion as of August 1, 2025. Its market cap has increased by 597.43% in one year.
Market Cap
3.25B
Enterprise Value
2.55B
Revenue
97.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.78
Market Cap Chart
Since November 20, 2020, Antengene Corporation's market cap has decreased from 12.21B to 3.25B, a decrease of -73.41%. That is a compound annual growth rate of -24.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 3.25B | 635.38% |
| Dec 31, 2024 | 441.64M | -67.28% |
| Dec 29, 2023 | 1.35B | -61.17% |
| Dec 30, 2022 | 3.48B | -46.78% |
| Dec 31, 2021 | 6.53B | -43.23% |
| Dec 31, 2020 | 11.50B | -5.82% |
| Nov 20, 2020 | 12.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 278.50B |
| Hansoh Pharmaceutical Group Company | 207.51B |
| Innovent Biologics | 158.98B |
| JD Health International | 156.01B |
| Akeso | 140.29B |
| Sino Biopharmaceutical | 130.92B |
| WuXi Biologics | 127.57B |
| CSPC Pharmaceutical Group | 113.07B |